Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar 26;16(3):e56982.
doi: 10.7759/cureus.56982. eCollection 2024 Mar.

Exploring the Implications of Golgi Apparatus Dysfunction in Bone Diseases

Affiliations
Review

Exploring the Implications of Golgi Apparatus Dysfunction in Bone Diseases

Georgian L Iacobescu et al. Cureus. .

Abstract

The Golgi apparatus is an organelle responsible for protein processing, sorting, and transport in cells. Recent research has shed light on its possible role in the pathogenesis of various bone diseases. This review seeks to explore its significance in osteoporosis, osteogenesis imperfecta, and other bone conditions such as dysplasias. Numerous lines of evidence demonstrate that perturbations to Golgi apparatus function can disrupt post-translational protein modification, folding and trafficking functions crucial for bone formation, mineralization, and remodeling. Abnormalities related to glycosylation, protein sorting, or vesicular transport in Golgi have been associated with altered osteoblast and osteoclast function, compromised extracellular matrix composition, as well as disrupted signaling pathways involved with homeostasis of bones. Mutations or dysregulation of Golgi-associated proteins, including golgins and coat protein complex I and coat protein complex II coat components, have also been implicated in bone diseases. Such genetic alterations may disrupt Golgi structure, membrane dynamics, and protein transport, leading to bone phenotype abnormalities. Understanding the links between Golgi apparatus dysfunction and bone diseases could provide novel insights into disease pathogenesis and potential therapeutic targets. Future research should focus on unraveling specific molecular mechanisms underlying Golgi dysfunction associated with bone diseases to develop targeted interventions for restoring normal bone homeostasis while decreasing clinical manifestations associated with these issues.

Keywords: bone diseases; glycosylation; golgi apparatus; protein sorting; signaling pathways; vesicular trafficking.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Golgi apparatus dysfunction-associated disorders.
These malfunctions arise from abnormal functioning or structural alterations of the Golgi apparatus, an organelle responsible for protein modification, sorting, and trafficking within cells. The “X” on the Metabolic Syndromes pathway represents the altering of a normal metabolism. This is an original figure created by the authors.
Figure 2
Figure 2. Heparan sulfate (HS) biosynthesis.
HS synthesis begins with a tetrasaccharide on a core protein to make HSPG: xylose, two galactoses, and glucuronic acid. EXTL2’s enzyme initiates the chain with N-acetylglucosamine. Exostosin-1 and 2 then alternately extend it with glucuronic acid and N-acetylglucosamine, producing full HS proteoglycans. EXT1 and EXT2: EXT1 stands for exostosin glycosyltransferase 1 and EXT2 for exostosin glycosyltransferase 2. EXTL1, EXTL2, and EXTL3: EXTL stands for exostosin-like, and these genes also encode enzymes involved in HS chain elongation. EXTL1 is exostosin-like 1, EXTL2 is exostosin-like 2, and EXTL3 is exostosin-like 3. GlcNAc: N-acetylglucosamine, which is a sugar molecule that serves as a building block for polymers such as HS. GlcUA: Glucuronic acid, another sugar component of HS. Gal: Galactose, a type of sugar molecule. Xyl: Xylose, a sugar molecule that links to serine or threonine residues on proteins during glycosylation. Ser/Thr: These represent the amino acids serine (Ser) and threonine (Thr), which are the sites on proteins where O-glycosylation can occur. GlcA TI, Gal TI, and Gal TII: These are likely abbreviations for specific glycosyltransferases that add glucuronic acid (GlcA) and galactose (Gal) residues during the glycosylation process. TI and TII: Type I and type II isoenzymes of these glycosyltransferases. Xyt T: This might stand for xylosyltransferase, the enzyme that adds a xylose molecule to serine or threonine residues on proteins, starting the glycosylation process. The “n” in the image represents the polymerization process, indicating that the sugars are added repeatedly to create a long chain. This is an original figure created by the authors.
Figure 3
Figure 3. The evolution of three types of intracellular transport vesicles.
The evolution of three types of intracellular transport vesicles involved with intracellular transport: coat protein complex I, coat protein complex II, and Clathrin-coated vesicles. This visual depiction emphasizes their complexity and interconnectivity. This is an original figure created by the authors.

References

    1. Camillo Golgi and the discovery of the Golgi apparatus. Dröscher A. Histochem Cell Biol. 1998;109:425–430. - PubMed
    1. The Golgi apparatus: 100 years of progress and controversy. Farquhar MG, Palade GE. Trends Cell Biol. 1998;8:2–10. - PMC - PubMed
    1. The role of the Golgi apparatus in disease (review) Liu J, Huang Y, Li T, Jiang Z, Zeng L, Hu Z. Int J Mol Med. 2021;47:38. - PMC - PubMed
    1. An important step in neuroscience: Camillo Golgi and his discoveries. Saceleanu VM, Covache-Busuioc RA, Costin HP, Glavan LA, Ciurea AV. Cells. 2022;11:4112. - PMC - PubMed
    1. Unraveling molecular and genetic insights into neurodegenerative diseases: advances in understanding Alzheimer's, Parkinson's, and Huntington's diseases and amyotrophic lateral sclerosis. Ciurea AV, Mohan AG, Covache-Busuioc RA, Costin HP, Glavan LA, Corlatescu AD, Saceleanu VM. Int J Mol Sci. 2023;24:10809. - PMC - PubMed

LinkOut - more resources